Land: Sverige
Språk: svenska
Källa: Läkemedelsverket (Medical Products Agency)
Tanacetum parthenium (mattram) torkad ört; pulvriserat växtmaterial
Sana Pharma Medical AS
N02CX
Tanacetum parthenium (feverfew) dried herb; powdered plant material
Kapsel, hård
Tanacetum parthenium (mattram) torkad ört; pulvriserat växtmaterial 100 mg Aktiv substans
Receptfritt
Förpacknings: Blister, 30 kapslar; Blister, 60 kapslar; Blister, 90 kapslar; Blister, 120 kapslar
Registrerad
2018-07-23
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT GLITINUM HARD CAPSULES Powdered feverfew TRADITIONAL HERBAL MEDICINAL PRODUCT READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor,pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you feel worse or do not feel better after 2 months. WHAT IS IN THIS LEAFLET 1. What Glitinum is and what it is used for 2. What you need to know before you take Glitinum 3. How to take Glitinum 4. Possible side effects 5. How to store Glitinum 6. Contents of the pack and other information 1. WHAT GLITINUM IS AND WHAT IT IS USED FOR Glitinum is a traditional herbal medicinal product for the prevention of migraine headaches after serious conditions have been excluded by a medical doctor. The product is a traditional herbal medicinal product for use in the specified indication exclusively based upon long-standing use. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE GLITINUM DO NOT TAKE THIS MEDICINE: - if you are allergic to feverfew or other plants of the Asteraceae (Compositae) family or to any of the other ingredients of this medicine (listed in section 6). WARNINGS AND PRECAUTIONS If the symptoms worsen during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. CHILDREN AND ADOLESCENTS This medicine shall not be used in children and adolescents under 18 years of age due to lack of adequate data. OTHER MEDICINES AND GLITINUM In the event of contacting a doctor or a qualified health care practitioner, remember to tell that you are taking or recently have taken this non-prescriptive medicine. No effects of using other drugs Läs hela dokumentet
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Glitinum, hard capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains: 100 mg of powdered _Tanacetum parthenium_ (L.) Schulz Bip., (feverfew), herba corresponding to 100 mg of dried herb of feverfew. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Hard capsule White opaque hard capsule (19.4x7.0 mm). The capsule contents are beige-greenish. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Traditional herbal medicinal product indicated for the prophylaxis of migraine headaches after serious conditions have been excluded by a medical doctor. The product is a traditional herbal medicinal product for use in specified indication exclusively based upon long-standing use. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults and elderly_ One capsule daily. _Paediatric population_ The use of Glitinum in children and adolescents under 18 years of age is contraindicated (see section 4.3). Method of administration Oral use: Capsules should be swallowed whole (with water or a little liquid). The capsules should not be chewed. Duration of use If the symptoms persist longer than 2 months during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Glitinum should not be used longer than 3 months. 2 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or other plants of the Asteraceae (Compositae) family or to any of the excipients listed in section 6.1. Paediatric population The use in children and adolescents under 18 years of age is contraindicated due to lack of adequate data. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE If the symptoms worsen during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION No interaction studies have been performed. No interactions have been reported. 4.6 FERTILITY, PREGNANCY AND LACTATION Läs hela dokumentet